Covid-19: Vaccination Programme

Baroness Sheehan Excerpts

Tuesday 22nd February 2022 Lords Chamber

[Lord Sharpe of Epsom (Con)]

My Lords, I am not familiar with the tax incentives that may have been offered, but we have provided technical support to develop business cases for, for example, Biovac to manufacture vaccines in South Africa, the Institut Pasteur in Dakar, Senegal, and to the Moroccan Government. The technical support helped to catalyse investment that will see Covid-19 vaccines produced on the African continent in 2022. We also welcome the work of the COVAX supply chain and manufacturing task force, which brings together partners to identify immediate and longer-term actions to increase the volume and security of global vaccine supply.

[Baroness Sheehan (LD)]

My Lords, this March the UK is hosting the pandemic preparedness summit, at which CEPI, the Coalition for Epidemic Preparedness Innovations, is aiming to raise $3.5 billion for its 2022-26 strategic period. Will the UK Government take this opportunity to commit £300 million and act as a diplomatic leader to ensure that CEPI has the resources it needs to continue its crucial work?

[Lord Sharpe of Epsom (Con)]

The noble Baroness is quite right: the UK is hosting the global pandemic preparedness summit on 8 March this year, and that will raise funds to achieve CEPI’s goal to develop vaccines against new threats in 100 days and rapidly scale up regional manufacturing for affordable global supply. CEPI’s new five-year strategy aims to develop vaccines to prevent future pandemics, cutting the time it takes to develop new vaccines from 300 to 100 days. The UK is a long-term partner of CEPI and one of its biggest supporters, giving £276 million in funding since 2018. There will be a pledge of more money towards CEPI at the replenishment summit next month, but I am afraid that I do not know the number. I could go on about CEPI, but I think that is enough.